News on Medial

Cognizant, Nvidia tap generative AI to boost drug discoveries

Economic Times · 8m

Cognizant, a global IT services and consulting company, is utilizing generative AI (gen AI) technology in collaboration with Nvidia's BioNeMo platform to enhance drug discovery productivity and accelerate market reach in the health sciences sector. By leveraging gen AI, clinical researchers can analyze large datasets, predict drug compound interactions, and create new paths for drug development. This breakthrough technology has the potential to revolutionize the drug discovery process, making it faster and more accessible. Cognizant aims to provide clients with model-making services and pretrained models, simplifying the training and customization of enterprise models. They will establish an Nvidia AI Center of Excellence to further innovate with Nvidia technologies.